Evidence map›Paper›PMID 42007413›Full record

ArticleMethodsX2026

Improving mycotoxin enzyme immunoassay performance by optimizing formaldehyde-mediated hapten-protein conjugation: an α-cyclopiazonic acid case study.

Leon Hart, Christina Rehagel, Daniela Schale, Madeleine Plötz, Ewald Usleber

Abstract read
In one paragraph

Article in MethodsX, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Leon HartChair of Dairy Sciences, Institute of Veterinary Food Science, Justus-Liebig-University, Giessen, Germany.
Christina RehagelFaculty of Food and Nutrition Sciences, Hochschule Niederrhein University of Applied Sciences, Mönchengladbach, Germany.
Daniela SchaleInstitute of Food Quality and Food Safety, University of Veterinary Medicine, Hannover, Germany.
Madeleine PlötzInstitute of Food Quality and Food Safety, University of Veterinary Medicine, Hannover, Germany.
Ewald UsleberChair of Dairy Sciences, Institute of Veterinary Food Science, Justus-Liebig-University, Giessen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enzyme immunoassays (EIAs) for small molecules often suffer from limited sensitivity or high non-specific background. This study presents a reproducible strategy to improve EIA performance by optimizing hapten-protein conjugation conditions. Using an immunoassay for the mycotoxin α-cyclopiazonic acid (α-CPA) as a case study, key parameters of the formaldehyde-mediated (Mannich) condensation reaction for synthesizing a hapten-bovine serum albumin conjugate were systematically investigated. Variation of reaction temperature (8-37°C) and time (0.25-72 h) showed that short reaction times at low temperature markedly improved assay performance. Under optimized conditions (8°C, 15 min), the detection limit improved from >100 ng/mL to 2.4 ± 0.2 ng/mL, with a strong reduction in non-specific background. The results demonstrate that targeted optimization of hapten-protein conjugation can significantly enhance EIA sensitivity and specificity, which helps to reduce the number of laboratory animals for antibody production. The approach is readily transferable to other indole-containing mycotoxins and was successfully applied to determine α-CPA in fungal agar plugs from mold-ripened cheeses. This study highlights an important aspect of conjugation conditions during immunoassay optimization. •Systematic optimization of formaldehyde-mediated hapten-protein conjugation for EIAs •Improved assay sensitivity and background without new antibody production •Transferable strategy demonstrated for α-CPA analysis in complex fungal samples.

Indexed as

Assay optimizationCyclopiazonic acidEnzyme immunoassayFormaldehyde condensationHapten-protein conjugationSmall-molecule immunoassay

Identifiers

PMID42007413
PMCPMC13091210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.